SunTrust Banks Raises Humana (NYSE:HUM) Price Target to $335.00

Humana (NYSE:HUM) had its price target boosted by SunTrust Banks to $335.00 in a research report report published on Thursday, November 7th, The Fly reports. They currently have a hold rating on the insurance provider’s stock. SunTrust Banks also issued estimates for Humana’s Q4 2019 earnings at $2.22 EPS, FY2019 earnings at $17.78 EPS, Q1 2020 earnings at $4.80 EPS, Q2 2020 earnings at $5.94 EPS, Q3 2020 earnings at $5.04 EPS, Q4 2020 earnings at $2.86 EPS and FY2020 earnings at $18.64 EPS. The analysts noted that the move was a valuation call.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

HUM has been the subject of a number of other research reports. Deutsche Bank started coverage on Humana in a report on Thursday, September 12th. They issued a hold rating and a $300.00 price target for the company. Berenberg Bank reissued a buy rating on shares of Humana in a report on Monday, October 21st. Mizuho assumed coverage on Humana in a research note on Thursday, October 17th. They set a buy rating and a $316.00 price objective on the stock. Canaccord Genuity restated a buy rating on shares of Humana in a research note on Monday, October 21st. Finally, JPMorgan Chase & Co. upped their price objective on Humana from $288.00 to $322.00 and gave the company an overweight rating in a research note on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fourteen have assigned a buy rating to the stock. Humana presently has a consensus rating of Buy and an average price target of $323.81.

Shares of NYSE:HUM opened at $335.55 on Thursday. Humana has a 12 month low of $225.65 and a 12 month high of $340.48. The business has a 50-day moving average of $282.93 and a two-hundred day moving average of $273.10. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.83 and a quick ratio of 1.83. The firm has a market capitalization of $42.11 billion, a PE ratio of 23.06, a P/E/G ratio of 1.36 and a beta of 0.85.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, November 6th. The insurance provider reported $5.03 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $4.58 by $0.45. The company had revenue of $16.24 billion during the quarter, compared to the consensus estimate of $16.15 billion. Humana had a return on equity of 22.32% and a net margin of 4.06%. The company’s revenue was up 14.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $4.58 earnings per share. As a group, research analysts anticipate that Humana will post 17.77 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date is Monday, December 30th. Humana’s payout ratio is currently 15.12%.

In other news, insider Brian P. Leclaire sold 7,239 shares of the firm’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $289.70, for a total transaction of $2,097,138.30. Following the completion of the sale, the insider now directly owns 12,994 shares of the company’s stock, valued at approximately $3,764,361.80. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.54% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in HUM. Endurance Wealth Management Inc. boosted its position in shares of Humana by 354.5% in the third quarter. Endurance Wealth Management Inc. now owns 100 shares of the insurance provider’s stock worth $26,000 after buying an additional 78 shares during the period. Whittier Trust Co. acquired a new stake in shares of Humana in the second quarter worth $27,000. Next Capital Management LLC acquired a new stake in shares of Humana in the second quarter worth $27,000. Quest Capital Management Inc. ADV acquired a new stake in shares of Humana in the third quarter worth $30,000. Finally, Advantage Investment Management LLC boosted its position in shares of Humana by 287.1% in the second quarter. Advantage Investment Management LLC now owns 120 shares of the insurance provider’s stock worth $32,000 after buying an additional 89 shares during the period. 93.08% of the stock is owned by institutional investors and hedge funds.

Humana Company Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Article: 52-Week Highs and Lows

The Fly

Analyst Recommendations for Humana (NYSE:HUM)

Leave a Reply

Your email address will not be published. Required fields are marked *

*